Clinical trial of the efficacy of pegylated interferon (PEG-IFNalpha-2a) [peginterferon-alpha-2a] alone in Egyptian patients with acute hepatitis C
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2008
At a glance
- Drugs Peginterferon alfa-2a (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 07 Feb 2008 Status changed from recruiting to completed.
- 12 Oct 2007 The expected completion date for this trial is now 1 Nov 2007.
- 18 Nov 2005 New trial record.